
The Economic and Strategic Implications of a Major Drug Injury Lawsuit in the Pharmaceutical Sector
In an era where pharmaceutical innovation intersects with stringent regulatory oversight, a recent drug injury lawsuit against a leading company highlights the vulnerabilities in the







